TransAct Technologies (TACT) director converts RSUs into 21,800 common shares

Rhea-AI Filing Summary

TransAct Technologies Inc. director Randall S. Friedman reported multiple stock award vestings that converted into common shares. On February 27, 28, March 1 and March 2, 2026, he exercised Restricted Stock Units into matching amounts of common stock at a price of $0.0000 per share.

The RSUs were originally granted between 2022 and 2025 under the company’s 2014 Equity Incentive Plan, vesting 25% annually and converting on a one-for-one basis into common stock. After these conversions, Friedman directly owned 21,800 shares of TransAct common stock, with no reported share sales.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Friedman Randall S

(Last) (First) (Middle)

2319 WHITNEY AVENUE

(Street)

HAMDEN CT 06518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		M		2,850	A	(1)	17,275	D
Common Stock	02/28/2026		M		1,675	A	(2)	18,950	D
Common Stock	03/01/2026		M		1,600	A	(3)	20,550	D
Common Stock	03/02/2026		M		1,250	A	(4)	21,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/27/2026		M			2,850	(1)	(1)	Common Stock	2,850	(1)	8,550	D
Restricted Stock Units	(2)	02/28/2026		M			1,675	(2)	(2)	Common Stock	1,675	(2)	3,350	D
Restricted Stock Units	(3)	03/01/2026		M			1,600	(3)	(3)	Common Stock	1,600	(3)	1,600	D
Restricted Stock Units	(4)	03/02/2026		M			1,250	(4)	(4)	Common Stock	1,250	(4)	0	D

Explanation of Responses:

1. Restricted Stock Units issued on February 27, 2025 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

2. Restricted Stock Units issued on February 29, 2024 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

3. Restricted Stock Units issued on March 1, 2023 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

4. Restricted Stock Units issued on March 2, 2022 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, vesting 25% annually commencing on the first anniversary of the date of grant that have converted to common stock on a one-for-one basis.

	/s/Madison Gallagher, Attorney-in-Fact for Randall S. Friedman	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did TransAct Technologies (TACT) report for Randall S. Friedman?

TransAct director Randall S. Friedman reported several exercises of Restricted Stock Units that converted into common stock. These transactions occurred between February 27 and March 2, 2026, and involved derivative exercises rather than open-market stock purchases or sales.

How many TransAct Technologies (TACT) shares does Randall S. Friedman hold after these transactions?

After the reported conversions, Randall S. Friedman directly owned 21,800 shares of TransAct Technologies common stock. This total reflects the impact of the recent Restricted Stock Unit exercises disclosed in the filing, with no accompanying reported sales of common shares.

What type of securities did Randall S. Friedman exercise at TransAct Technologies (TACT)?

Friedman exercised Restricted Stock Units that converted into common stock. Each RSU converted on a one-for-one basis into TransAct common shares, consistent with the company’s equity incentive plan and the vesting schedules described in the filing footnotes.

On what dates were the TransAct Technologies (TACT) RSU conversions by Randall S. Friedman effective?

The RSU conversions to common stock were effective on February 27, 2026, February 28, 2026, March 1, 2026, and March 2, 2026. Each date corresponds to vested Restricted Stock Units being exercised and settled into TransAct common shares.

Under which plan were Randall S. Friedman’s TransAct Technologies (TACT) RSUs granted?

The Restricted Stock Units were granted under TransAct Technologies’ 2014 Equity Incentive Plan, as Amended and Restated. Footnotes explain that awards from 2022, 2023, 2024, and 2025 vest 25% annually and convert into common stock on a one-for-one basis.

Did Randall S. Friedman buy or sell TransAct Technologies (TACT) shares on the open market?

The filing shows exercises and conversions of Restricted Stock Units into common stock, not open-market purchases or sales. Transactions are coded as derivative exercises at a price of $0.0000 per share, with no reported sales of the resulting common shares.